CA3171027A1 - Systemes et methodes pour la determination non invasive de l'infection par le coronavirus covid-19 - Google Patents
Systemes et methodes pour la determination non invasive de l'infection par le coronavirus covid-19 Download PDFInfo
- Publication number
- CA3171027A1 CA3171027A1 CA3171027A CA3171027A CA3171027A1 CA 3171027 A1 CA3171027 A1 CA 3171027A1 CA 3171027 A CA3171027 A CA 3171027A CA 3171027 A CA3171027 A CA 3171027A CA 3171027 A1 CA3171027 A1 CA 3171027A1
- Authority
- CA
- Canada
- Prior art keywords
- membrane
- virus
- sampler
- collected media
- individuals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 669
- 208000025721 COVID-19 Diseases 0.000 title claims 45
- 208000001528 Coronaviridae Infections Diseases 0.000 title description 2
- 239000012528 membrane Substances 0.000 claims abstract description 691
- 241000700605 Viruses Species 0.000 claims abstract description 600
- 238000001514 detection method Methods 0.000 claims abstract description 175
- 239000000443 aerosol Substances 0.000 claims abstract description 136
- 150000001875 compounds Chemical class 0.000 claims abstract description 131
- 238000004458 analytical method Methods 0.000 claims abstract description 4
- 238000004422 calculation algorithm Methods 0.000 claims description 297
- 230000005670 electromagnetic radiation Effects 0.000 claims description 249
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 152
- 102000004169 proteins and genes Human genes 0.000 claims description 137
- 108090000623 proteins and genes Proteins 0.000 claims description 137
- 150000004677 hydrates Chemical class 0.000 claims description 136
- 238000000862 absorption spectrum Methods 0.000 claims description 121
- 238000010801 machine learning Methods 0.000 claims description 121
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 claims description 114
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 114
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 108
- 102000015696 Interleukins Human genes 0.000 claims description 90
- 108010063738 Interleukins Proteins 0.000 claims description 90
- 102000004889 Interleukin-6 Human genes 0.000 claims description 88
- 108090001005 Interleukin-6 Proteins 0.000 claims description 88
- 229940100601 interleukin-6 Drugs 0.000 claims description 88
- 238000003909 pattern recognition Methods 0.000 claims description 86
- 102000010789 Interleukin-2 Receptors Human genes 0.000 claims description 85
- 108010038453 Interleukin-2 Receptors Proteins 0.000 claims description 85
- 239000000463 material Substances 0.000 claims description 85
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 claims description 76
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 76
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 76
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 76
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 claims description 76
- 239000001569 carbon dioxide Substances 0.000 claims description 76
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 76
- ZAJNGDIORYACQU-UHFFFAOYSA-N decan-2-one Chemical compound CCCCCCCCC(C)=O ZAJNGDIORYACQU-UHFFFAOYSA-N 0.000 claims description 76
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 claims description 76
- FXHGMKSSBGDXIY-UHFFFAOYSA-N heptanal Chemical compound CCCCCCC=O FXHGMKSSBGDXIY-UHFFFAOYSA-N 0.000 claims description 76
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 claims description 76
- VKCYHJWLYTUGCC-UHFFFAOYSA-N nonan-2-one Chemical compound CCCCCCCC(C)=O VKCYHJWLYTUGCC-UHFFFAOYSA-N 0.000 claims description 76
- KYWIYKKSMDLRDC-UHFFFAOYSA-N undecan-2-one Chemical compound CCCCCCCCCC(C)=O KYWIYKKSMDLRDC-UHFFFAOYSA-N 0.000 claims description 76
- CRBJBYGJVIBWIY-UHFFFAOYSA-N 2-isopropylphenol Chemical compound CC(C)C1=CC=CC=C1O CRBJBYGJVIBWIY-UHFFFAOYSA-N 0.000 claims description 74
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 71
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 claims description 70
- 238000000513 principal component analysis Methods 0.000 claims description 67
- YWHLKYXPLRWGSE-UHFFFAOYSA-N Dimethyl trisulfide Chemical compound CSSSC YWHLKYXPLRWGSE-UHFFFAOYSA-N 0.000 claims description 66
- 210000004027 cell Anatomy 0.000 claims description 63
- 239000002775 capsule Substances 0.000 claims description 54
- 238000012549 training Methods 0.000 claims description 51
- 230000001133 acceleration Effects 0.000 claims description 50
- 238000012545 processing Methods 0.000 claims description 50
- 108010002586 Interleukin-7 Proteins 0.000 claims description 46
- 102000014962 Monocyte Chemoattractant Proteins Human genes 0.000 claims description 46
- 108010064136 Monocyte Chemoattractant Proteins Proteins 0.000 claims description 46
- 206010054094 Tumour necrosis Diseases 0.000 claims description 46
- 108010067390 Viral Proteins Proteins 0.000 claims description 46
- 230000001413 cellular effect Effects 0.000 claims description 46
- 230000001939 inductive effect Effects 0.000 claims description 46
- 230000002757 inflammatory effect Effects 0.000 claims description 46
- 210000002540 macrophage Anatomy 0.000 claims description 46
- 230000004936 stimulating effect Effects 0.000 claims description 46
- -1 aromatic alcohols Chemical class 0.000 claims description 45
- 102000004127 Cytokines Human genes 0.000 claims description 44
- 108090000695 Cytokines Proteins 0.000 claims description 44
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 44
- 229910052710 silicon Inorganic materials 0.000 claims description 44
- 238000012360 testing method Methods 0.000 claims description 44
- 230000011664 signaling Effects 0.000 claims description 43
- 239000010703 silicon Substances 0.000 claims description 43
- 239000006096 absorbing agent Substances 0.000 claims description 42
- 150000002894 organic compounds Chemical class 0.000 claims description 41
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 claims description 38
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 38
- 229910021529 ammonia Inorganic materials 0.000 claims description 38
- 150000002576 ketones Chemical class 0.000 claims description 38
- 239000000203 mixture Substances 0.000 claims description 38
- 239000001272 nitrous oxide Substances 0.000 claims description 38
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 38
- VEAFKIYNHVBNIP-UHFFFAOYSA-N 1,3-Diphenylpropane Chemical compound C=1C=CC=CC=1CCCC1=CC=CC=C1 VEAFKIYNHVBNIP-UHFFFAOYSA-N 0.000 claims description 37
- VCHOFVSNWYPAEF-UHFFFAOYSA-N 1-(3-acetylphenyl)ethanone Chemical compound CC(=O)C1=CC=CC(C(C)=O)=C1 VCHOFVSNWYPAEF-UHFFFAOYSA-N 0.000 claims description 37
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims description 37
- 239000005431 greenhouse gas Substances 0.000 claims description 37
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 claims description 35
- 150000001299 aldehydes Chemical class 0.000 claims description 35
- 150000002484 inorganic compounds Chemical class 0.000 claims description 35
- 229910010272 inorganic material Inorganic materials 0.000 claims description 35
- 208000024891 symptom Diseases 0.000 claims description 35
- 206010037660 Pyrexia Diseases 0.000 claims description 33
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 33
- 230000036772 blood pressure Effects 0.000 claims description 32
- 230000036760 body temperature Effects 0.000 claims description 32
- 230000036387 respiratory rate Effects 0.000 claims description 32
- 210000004243 sweat Anatomy 0.000 claims description 32
- 230000003287 optical effect Effects 0.000 claims description 31
- NMRPBPVERJPACX-UHFFFAOYSA-N (3S)-octan-3-ol Natural products CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 claims description 30
- WOFPPJOZXUTRAU-UHFFFAOYSA-N 2-Ethyl-1-hexanol Natural products CCCCC(O)CCC WOFPPJOZXUTRAU-UHFFFAOYSA-N 0.000 claims description 30
- 238000004891 communication Methods 0.000 claims description 27
- 239000007789 gas Substances 0.000 claims description 25
- 208000002979 Influenza in Birds Diseases 0.000 claims description 22
- 206010064097 avian influenza Diseases 0.000 claims description 22
- 230000005611 electricity Effects 0.000 claims description 22
- 206010022000 influenza Diseases 0.000 claims description 22
- CTMHWPIWNRWQEG-UHFFFAOYSA-N trans cyclohexenyl ester Natural products CC1=CCCCC1 CTMHWPIWNRWQEG-UHFFFAOYSA-N 0.000 claims description 22
- 230000009466 transformation Effects 0.000 claims description 22
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 21
- 229920000877 Melamine resin Polymers 0.000 claims description 21
- 239000006260 foam Substances 0.000 claims description 21
- 229910021389 graphene Inorganic materials 0.000 claims description 21
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 claims description 21
- 230000005855 radiation Effects 0.000 claims description 21
- 238000005070 sampling Methods 0.000 claims description 21
- 230000001755 vocal effect Effects 0.000 claims description 21
- 238000013459 approach Methods 0.000 claims description 18
- 238000000605 extraction Methods 0.000 claims description 18
- 239000003000 extruded plastic Substances 0.000 claims description 18
- 239000013598 vector Substances 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 16
- 210000004379 membrane Anatomy 0.000 claims 522
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 28
- 230000009977 dual effect Effects 0.000 claims 12
- 238000010521 absorption reaction Methods 0.000 claims 11
- 238000007789 sealing Methods 0.000 claims 10
- 239000002699 waste material Substances 0.000 claims 10
- 102000005962 receptors Human genes 0.000 claims 7
- 108020003175 receptors Proteins 0.000 claims 7
- 229920004943 Delrin® Polymers 0.000 claims 6
- 229930040373 Paraformaldehyde Natural products 0.000 claims 6
- 230000008878 coupling Effects 0.000 claims 6
- 238000010168 coupling process Methods 0.000 claims 6
- 238000005859 coupling reaction Methods 0.000 claims 6
- 229920006324 polyoxymethylene Polymers 0.000 claims 6
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims 4
- 239000004810 polytetrafluoroethylene Substances 0.000 claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- JWQKMEKSFPNAIB-UHFFFAOYSA-N 1-methyl-5-prop-1-en-2-ylcyclohexene Chemical compound CC(=C)C1CCC=C(C)C1 JWQKMEKSFPNAIB-UHFFFAOYSA-N 0.000 claims 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims 2
- 239000004809 Teflon Substances 0.000 claims 2
- 229920006362 Teflon® Polymers 0.000 claims 2
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 claims 1
- 239000001294 propane Substances 0.000 claims 1
- 238000003012 network analysis Methods 0.000 description 14
- 241000711573 Coronaviridae Species 0.000 description 8
- 229920000139 polyethylene terephthalate Polymers 0.000 description 5
- 239000005020 polyethylene terephthalate Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 description 2
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 206010041232 sneezing Diseases 0.000 description 2
- 102100034613 Annexin A2 Human genes 0.000 description 1
- 108090000668 Annexin A2 Proteins 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000282375 Herpestidae Species 0.000 description 1
- 208000025370 Middle East respiratory syndrome Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000011898 label-free detection Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 238000010223 real-time analysis Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/55—Specular reflectivity
- G01N21/552—Attenuated total reflection
- G01N21/553—Attenuated total reflection and using surface plasmons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/3581—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using far infrared light; using Terahertz radiation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/497—Physical analysis of biological material of gaseous biological material, e.g. breath
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N20/00—Machine learning
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N2021/775—Indicator and selective membrane
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/12—Circuits of general importance; Signal processing
- G01N2201/129—Using chemometrical methods
- G01N2201/1296—Using chemometrical methods using neural networks
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/08—Learning methods
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Software Systems (AREA)
- Data Mining & Analysis (AREA)
- Biophysics (AREA)
- Evolutionary Computation (AREA)
- Artificial Intelligence (AREA)
- Mathematical Physics (AREA)
- General Engineering & Computer Science (AREA)
- Computing Systems (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Medical Informatics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
L'invention concerne une méthode à haut rendement pour la détection sans marqueur, sans contact, non invasive et non destructive d'au moins un individu infecté par un virus ou exempt de virus par rapport à au moins un individu testé. La méthode comprend la collecte d'un échantillon de l'haleine expirée d'un sujet pour l'analyse de l'échantillon. La collecte comprend l'expiration du sujet dans au moins un échantillonneur et la collecte des aérosols et/ou de tout composé en suspension dans l'air à partir de l'haleine expirée en faisant passer l'haleine expirée à travers une membrane métamatériau à l'intérieur de l'échantillonneur. La membrane métamatériau est disposée transversalement à un flux d'haleine expirée à travers l'échantillonneur. La méthode comprend en outre l'analyse de l'échantillon pour la détection d'au moins un individu infecté par un virus parmi au moins un individu testé.
Applications Claiming Priority (41)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062992627P | 2020-03-20 | 2020-03-20 | |
| US62/992,627 | 2020-03-20 | ||
| US202063000077P | 2020-03-26 | 2020-03-26 | |
| US63/000,077 | 2020-03-26 | ||
| US202063002404P | 2020-03-31 | 2020-03-31 | |
| US63/002,404 | 2020-03-31 | ||
| IL273709 | 2020-03-31 | ||
| IL273709A IL273709A (en) | 2020-03-31 | 2020-03-31 | A system and method for non-invasively detection of coronoavirus (covid-19) |
| US202063012682P | 2020-04-20 | 2020-04-20 | |
| US202063012672P | 2020-04-20 | 2020-04-20 | |
| US63/012,682 | 2020-04-20 | ||
| US63/012,672 | 2020-04-20 | ||
| US202063015723P | 2020-04-27 | 2020-04-27 | |
| US202063015714P | 2020-04-27 | 2020-04-27 | |
| US63/015,723 | 2020-04-27 | ||
| US63/015,714 | 2020-04-27 | ||
| US202063032735P | 2020-06-01 | 2020-06-01 | |
| US202063032732P | 2020-06-01 | 2020-06-01 | |
| US63/032,735 | 2020-06-01 | ||
| US63/032,732 | 2020-06-01 | ||
| US202063038920P | 2020-06-15 | 2020-06-15 | |
| US202063038921P | 2020-06-15 | 2020-06-15 | |
| US63/038,921 | 2020-06-15 | ||
| US63/038,920 | 2020-06-15 | ||
| US202063051399P | 2020-07-14 | 2020-07-14 | |
| US202063051398P | 2020-07-14 | 2020-07-14 | |
| US63/051,398 | 2020-07-14 | ||
| US63/051,399 | 2020-07-14 | ||
| US202063057318P | 2020-07-28 | 2020-07-28 | |
| US202063057319P | 2020-07-28 | 2020-07-28 | |
| US63/057,319 | 2020-07-28 | ||
| US63/057,318 | 2020-07-28 | ||
| US202063075324P | 2020-09-08 | 2020-09-08 | |
| US202063075316P | 2020-09-08 | 2020-09-08 | |
| US63/075,324 | 2020-09-08 | ||
| US63/075,316 | 2020-09-08 | ||
| US202063111089P | 2020-11-09 | 2020-11-09 | |
| US202063111091P | 2020-11-09 | 2020-11-09 | |
| US63/111,091 | 2020-11-09 | ||
| US63/111,089 | 2020-11-09 | ||
| PCT/IB2021/052327 WO2021186412A1 (fr) | 2020-03-20 | 2021-03-19 | Systèmes et méthodes pour la détermination non invasive de l'infection par le coronavirus covid-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3171027A1 true CA3171027A1 (fr) | 2021-09-23 |
Family
ID=77770745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3171027A Pending CA3171027A1 (fr) | 2020-03-20 | 2021-03-19 | Systemes et methodes pour la determination non invasive de l'infection par le coronavirus covid-19 |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4121760A4 (fr) |
| CA (1) | CA3171027A1 (fr) |
| WO (1) | WO2021186412A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023118947A1 (fr) * | 2021-12-25 | 2023-06-29 | Ai Innobio Limited | Système et procédé de classification d'une substance de fluide par spectroscopie d'absorption |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100086750A1 (en) * | 2008-10-08 | 2010-04-08 | Lucent Technologies Inc. | Conductive polymer metamaterials |
| KR20170036890A (ko) * | 2015-09-23 | 2017-04-04 | 한국과학기술연구원 | 테라헤르츠 전자기파를 이용한 고민감성 및 고선택성 조류인플루엔자 바이러스 측정방법 및 이에 사용되는 디바이스 |
| JP6951854B2 (ja) * | 2017-03-29 | 2021-10-20 | 株式会社日立ハイテク | 容器搬送機構およびこれを備えた分析装置 |
| AU2018306664B2 (en) * | 2017-07-23 | 2024-03-28 | Terahertz Group Ltd. | A system and method for non-invasively determining egg properties |
| CN108211807B (zh) * | 2018-01-15 | 2021-11-23 | 浙江汇甬新材料有限公司 | 一种分子筛膜的处理方法 |
| CN110487751A (zh) * | 2019-09-03 | 2019-11-22 | 山东师范大学 | 石墨烯增敏ito超材料u型spr传感器 |
| CN115735123A (zh) * | 2020-03-24 | 2023-03-03 | 拉姆医疗公司有限责任公司 | 用于检测分析物的微电子传感器、使用微电子传感器的装置和方法 |
-
2021
- 2021-03-19 WO PCT/IB2021/052327 patent/WO2021186412A1/fr active Application Filing
- 2021-03-19 EP EP21771884.0A patent/EP4121760A4/fr active Pending
- 2021-03-19 CA CA3171027A patent/CA3171027A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4121760A4 (fr) | 2024-03-20 |
| EP4121760A1 (fr) | 2023-01-25 |
| WO2021186412A1 (fr) | 2021-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11510592B2 (en) | Systems and methods for non-invasive determination of COVID-19 coronavirus infection | |
| Barauna et al. | Ultrarapid on-site detection of SARS-CoV-2 infection using simple ATR-FTIR spectroscopy and an analysis algorithm: High sensitivity and specificity | |
| US11172846B2 (en) | Gas sampling device | |
| CN110353685B (zh) | 用于处理患者声音的方法与装置 | |
| Liu et al. | Automatic recognition of breast invasive ductal carcinoma based on terahertz spectroscopy with wavelet packet transform and machine learning | |
| van Mastrigt et al. | Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis | |
| Zulfiqar et al. | Hyperspectral imaging for bloodstain identification | |
| CN108088834B (zh) | 基于优化反向传播神经网络的包虫病血清拉曼光谱诊断仪 | |
| JP2003502661A (ja) | 多重検出システムおよび装置 | |
| Santos et al. | ATR-FTIR spectroscopy for virus identification: A powerful alternative | |
| US20110028808A1 (en) | Method and apparatus for examination of cancer, systemic lupus erythematosus (sle), or antiphospholipid antibody syndrome using near-infrared light | |
| Fufurin et al. | Numerical techniques for infrared spectra analysis of organic and inorganic volatile compounds for biomedical applications | |
| CN115735123A (zh) | 用于检测分析物的微电子传感器、使用微电子传感器的装置和方法 | |
| CA3171027A1 (fr) | Systemes et methodes pour la determination non invasive de l'infection par le coronavirus covid-19 | |
| Ye et al. | Accurate virus identification with interpretable Raman signatures by machine learning | |
| Dai et al. | Nondestructive detection for egg freshness based on hyperspectral scattering image combined with ensemble learning | |
| Bogomolov et al. | Synergy effect of combining fluorescence and mid infrared fiber spectroscopy for kidney tumor diagnostics | |
| US11045111B1 (en) | Real time breath analyzer for detecting volatile organic compounds and identifying diseases or disorders | |
| CN104297207B (zh) | 一种基于tdlas的激光呼气分析仪及系统 | |
| US11740171B2 (en) | Open-ended hollow coaxial cable resonator sensor | |
| Bhagya et al. | Speed of sound-based capnographic sensor with second-generation CNN for automated classification of cardiorespiratory abnormalities | |
| Siddiqui et al. | An approach to detect chronic obstructive pulmonary disease using UWB radar-based temporal and spectral features | |
| WO2007066589A1 (fr) | Procédé et appareil pour examiner et diagnostiquer une maladie liée au mode de vie utilisant une spectroscopie de proche infrarouge | |
| Kistenev et al. | Breathomics for lung cancer diagnosis | |
| Zhang et al. | Performance of Classification Models of Toxins Based on Raman Spectroscopy Using Machine Learning Algorithms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220923 |
|
| EEER | Examination request |
Effective date: 20220923 |
|
| EEER | Examination request |
Effective date: 20220923 |